Comparison of Demographic and Clinicopathological Characteristics of Basal Cell Carcinoma on the Nose and Other Sites of the Face: A Cross-Sectional Study

Document Type : Original


1 Department of Dermatology, Hajdaie Dermatology Clinic, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.

2 Family Health Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

3 Medical Student, School of Medicine, Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.

4 Physical Practitioner, Kermanshah University of Medical Sciences (KUMS), Kermanshah, Iran.


The clinicopathological characteristics of basal cell carcinoma (BCC) in different areas of the face, including the nose, are important and may be different. Accurate recognition of these characteristics may be necessary for the planning and selection of appropriate treatment.
Materials and Methods:
This cross-sectional study was conducted on 328 patients (131 females and 197 males) with 371 documented facial BCC in the West of Iran within 2013-2018. The demographic and clinicopathological data of the patients in the nose area were compared with other sites of the face by appropriate statistical methods.
Out of 371 lesions, 38.8% of the cases were on the nose, 75.8% were primary lesions, 97.8% had no perineural invasion, 89.2% were nodular, and 65.8% were of nodular clinical and pathologic type, which were the most common variables of patients. It was revealed that early-onset (p <0.001), smaller size (p <0.001), high-risk pathologic type (P=0.01), and recurrent lesions (P=0.013) were significantly higher in the nasal BCC. However, there was no significant difference between BCC in the nose and other sites of the face in terms of gender (P=0.654), high-risk clinical type (P=0.06), and perineural invasion (P=0.275).
Considering the nasal site as an important cosmetic unit, more limitation of the nose in performing any procedure, and presence of the more risk factors in the nose than in other areas of the face, the definite treatment of nasal BCC requires special attention, expertise, and experience.


  1. Ciążyńska M, Narbutt J, Woźniacka A, Lesiak A. Trends in basal cell carcinoma incidence rates: a 16-year retrospective study of a population in central Poland. Postepy dermatolog alergol 2018; 35(1):
  2. Venables ZC, Nijsten T, Wong KF, Autier P, Broggio J, Deas A, et al. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study. Br J Dermatol 2019; 181(3):474-482.
  3. Custódio G, Locks LH, Coan MF, Gonçalves CO, Trevisol DJ, Trevisol FS. Epidemiology of basal cell carcinomas in Tubarão, Santa Catarina (SC), Brazil between 1999 and 2008. An Bras Dermatol2010; 85(6):819-26.
  4. Di Stefani A, Chimenti S. Basal cell carcinoma: clinical and pathological features. G Ital Dermatol Venereol 2015; 150(4):385-91.
  5. Holtmann H, Fuhrmann V, Sander K, Sproll C, Kübler NR, Singh DD, et al.  Histopathological and patient-related characteristics of basal cell carcinomas of the head and neck influencing therapeutic management. Dermatol Reports 2018; 10(2): 7674.
  6. Al-Qarqaz F, Marji M, Bodoor K, Almomani R, Al Gargaz W, Alshiyab D, et al. Clinical and Demographic Features of Basal Cell Carcinoma in North Jordan. J Skin Cancer. 2018; 2018:2624054.
  7. Kavoussi H, Ebrahimi A, Rezaei M. Treatment and cosmetic outcome of superpulsed CO2 laser for basal cell carcinoma. Acta Dermatovenerol Alp Pannonica Adriat 2013; 22(3): 57–61.
  8. Kumar S, Mahajan BB, Kaur S, Yadav A, Singh N, Singh A.A Study of Basal Cell Carcinoma in South Asians for Risk Factor and Clinicopathological Characterization: A Hospital Based Study. J Skin Cancer 2014; 2014: 173582.
  9. Lam SM, Williams EF.3rd Anatomic considerations in aesthetic rhinoplasty. Facial Plast Surg 2002; 18(4):209–214.
  10.  Pawar SS, Garcia GJ, Kimbell JS, Rhee JS. Objective measures in aesthetic and functional nasal surgery: perspectives on nasal form and function. Facial Plastic Surgery 2010;26:320–327.
  11. Wollina U, Bennewitz A, Langner D. Basal Cell Carcinoma of the Outer Nose: Overview on Surgical Techniques and Analysis of 312 Patients. J Cutan Aesthet Surg 2014; 7(3): 143–150.
  12. Kiiski V, de Vries E, Flohil SC, Bijl MJ, Hofman A, Stricker BH, et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010; 146(8):848–55.
  13. Kavoussi H, Rezaei M, Isapour D, Doulabi SS. Clinical types and characteristics of basal cell carcinoma in Kermanshah province in 2009. J Dermatol Cosmetic. 2012; 3 (2): 100-109.
  14. Hoorens I, Vossaert K, Ongenae K, Brochez L. Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening. Br J Dermatol. 2016; 174: 1258–1265.
  15. Ocanha JP, Dias JT, Miot HA, Stolf HO, Marques ME, Abbade LP. Relapses and recurrences of basal cell face carcinomas. An Bras Dermatol 2011; 86:386-8.
  16. Ratner D, Lowe L , Johnson TM , Fader DJ.  Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer 2000 ;88 (7): 1605-13.
  17. Oda T, Kato H, Watanabe S, Morita A. Facial site distribution of basal cell carcinoma in Japanese. Exper Dermatol 2019; 28:69-71.
  18. Janjua OS, Qureshi SM. Basal cell carcinoma of the head and neck region: an analysis of 171 cases. J Skin Cancer 2012; 2012: 943472.
  19. Santos AB, Andrade NM, Brandão LG, Cernea CR. Which features of advanced head and neck basal cell carcinoma are associated with perineural invasion? Braz J Otorhinolaryngol 2017;83:94-97.